News
Top Small Cap Negative News Movers Premarket: LGVN: -55% Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel SN
Sep 17, 2026 · ThinkSabio Blog
Top Small Cap Negative News Movers Premarket:
LGVN: -55% Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel
SNYR: -48% Delisting Notice
DLXY: -42% Momentum Mover
NAMI: -20% Momentum Mover
17-SEP-2026 08:05 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
